ArticleEuropean journal of nuclear medicine and molecular imaging2018

Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.

Kazuhiro Kitajima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.